Relmada Therapeutics to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit

/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...

Related Keywords

New York ,United States ,Tim Mccarthy ,Cedric Ogorman ,Maged Shenouda ,Sergio Traversa ,Relmada Therapeutics Inc ,Securities Exchange ,Nasdaq ,Relmada Therapeutics ,Chief Executive Officer ,Chief Financial Officer ,Cedrico Gorman ,Chief Medical Officer ,Jefferies Inaugural Biotech ,Neuro Summit ,Private Securities Litigation Reform Act ,Securities Act ,Securities Exchange Act ,Nc ,